Canrythm 0.25mg Tablet is a medicine used for the treatment of heart failure in combination with other medicines. It helps to provide symptomatic relief by making the heart pump blood more efficiently. This medicine is also used to treat abnormal heart rhythm (arrhythmia).

Canrythm 0.25mg Tablet is a cardiac glycoside.

Uses of Canrythm Tablet

Benefits of Canrythm Tablet

In Heart failure

Heart failure means your heart is weak and cannot pump enough blood to your lungs and the rest of your body. The most common symptoms are breathlessness, tiredness, and swelling in your legs, ankles, abdomen and other parts of your body. Canrythm 0.25mg Tablet makes it easier for your heart to pump blood around your body and is therefore an effective treatment for heart failure.
This medicine will help relieve your symptoms, making you feel better and more energetic. You should make appropriate lifestyle changes (such as eating healthily and keeping active) to help this medicine be effective. Take it regularly and keep taking it even if you feel better.

In Arrhythmia

Canrythm 0.25mg Tablet is used to stabilize heart rhythms (particularly atrial fibrillation). It helps in normalizing an abnormal heart rhythm, preventing it from occurring in the first place, or slowing down the heart rate during an episode.

show less

Side effects of Canrythm Tablet

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of Canrythm

Visual impairment
Skin rash
Nausea
Vomiting
Diarrhea
Dizziness
Arrhythmia (irregular heartbeats)

How to use Canrythm Tablet

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Canrythm 0.25mg Tablet may be taken with or without food, but it is better to take it at a fixed time.

Safety advice

Alcohol

UNSAFE

It is unsafe to consume alcohol with Canrythm 0.25mg Tablet.

Pregnancy

CONSULT YOUR DOCTOR

Canrythm 0.25mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

Breast feeding

SAFE IF PRESCRIBED

Canrythm 0.25mg Tablet is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.

Driving

UNSAFE

Canrythm 0.25mg Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
.

Kidney

CAUTION

Canrythm 0.25mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Canrythm 0.25mg Tablet may be needed. Please consult your doctor.
Regular monitoring of kidney function tests, potassium, magnesium and calcium levels is advisable while you are taking this medicine.

Liver

SAFE IF PRESCRIBED

Canrythm 0.25mg Tablet is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Canrythm 0.25mg Tablet may not be needed in these patients. Please consult your doctor.

All substitutes

For informational purposes only. Consult a doctor before taking any medicines.

Canrythm 0.25mg Tablet

₹0.59/Tablet

Lanoxin Tablet

Glaxo SmithKline Pharmaceuticals Ltd

₹0.67/tablet

14% costlier

Dixin Tablet

Samarth Life Sciences Pvt Ltd

₹0.66/tablet

12% costlier

Digon Tablet

Tas Med India Pvt Ltd

₹0.7/tablet

19% costlier

Digitran 0.25mg Tablet

Macleods Pharmaceuticals Pvt Ltd

₹0.29/tablet

51% cheaper

Cardioxin 0.25mg Tablet

Novartis India Ltd

₹0.36/tablet

39% cheaper

View all substitutes

Quick tips

Take Canrythm 0.25mg Tablet at the same time every day.
Notify your doctor about any other medicines you're taking to avoid drug interactions.
Symptoms of Canrythm 0.25mg Tablet overdose include slow heartbeat, dizziness, lightheadedness and breathing problems.
Do not discontinue use of Canrythm 0.25mg Tablet without consulting your doctor even if you feel better. Stopping abruptly could worsen your condition.

Fact Box

Chemical Class

Cardiac glycosides

Habit Forming

Therapeutic Class

CARDIAC

Action Class

Cardiac glycosides

Patient concerns

What is BNP test? Pls explain. What is BNP ASSAY?My result is133.0 explain

Dr. Manju Singh

Homeopathy

BNP levels below 100 pg/mL indicate no heart failure. BNP levels of 100-300 pg/mL suggest heart failure is present. BNP levels above 300 pg/mL indicate mild heart failure. BNP levels above 600 pg/mL indicate moderate heart failure.The level of BNP in the blood increases when heart failure symptoms worsen, and decreases when the heart failure condition is stable

Myself is high B.P patients .There is some swelling in the face today . what is going on?

Dr. Pushkar Mani

Physician

Kidney damage or heart failure

Having difficulty in getting full erections. I take concor 1.25 and roseday 10 as prescribed for arrhythmia. What can be prescribed to me ?

Dr. Pranay Gandhi

Sexology

Treatment for erectile dysfunction: 1.stop smoking and alcohol 2.join a gym and reduce weight. Do weight lifting exercises. 3.tablet sildenafil or viagra 1 tablet 1 hour before sexual activity. 4.Get tested so that u don?t have any of the following causes: 1.heart diseases 2. diabetes 3.neurological problems 4.hormonal problems 5.drug side effects

Related ayurvedic ingredients

Fish Oil

Top Cardiologists

Dr. Balbir Singh

MBBS, MD, DM, Fellowship, Fellowship

4.8 ★

Dr. Dhananjay Kumar Jhamb

4.7 ★

4.8 ★

MBBS, MD, DNB, DM, Fellowship, Fellowship

4.7 ★

Dr. R. R. Kasliwal

MBBS, MD, DM, Fellowship

4.7 ★

Want to share the information?

Disclaimer:

Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.

References

Maron BA, Rocco TP. Pharmacotherapy of Congestive Heart Failure. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 801-84.
Zehnder JL. Drugs Used in Disorders of Coagulation. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 219-20.
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 406-407.
Teerlink JR, Sliwa K, Opie LH. Heart Failure. In: Opie LH, Gersh BJ, editors. Drugs for the Heart. 8th ed. Philadelphia, Pennsylvania: Elsevier Saunders; 2013. pp. 201-207.
Chaves RG, Lamounier JA. Breastfeeding and maternal medications. J Pediatr (Rio J). 2004;80(5 Suppl):S189-S198. [Accessed 15 Mar. 2019] (online) Available from:
Central Drugs Standard Control Organisation (CDSCO). Digoxin. [Accessed 15 Mar. 2019] (online) Available from:

Marketer details

Name: Canipla Care

Address: 596, 2nd Floor, KeshoRam Comlex, Sector-45 C, Chandigarh-160047.

Country of origin: India

The list of available options shown with the same composition has been prepared upon the advice of registered medical practitioners, pharmacists affiliated with TATA 1MG. TATA 1MG does not promote any pharmaceutical product of any particular company, and all recommendations are based on the medical opinion, advisories from specialist medical and pharmaceutical professionals.